NCT02899949View on ClinicalTrials.gov

Health Outcomes of Patients With Type 2 Diabetes Treated With Dapagliflozin in Conjunction With Insulin

CompletedOBSERVATIONAL
Enrollment

212

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

December 31, 2016

Conditions
Type 2 Diabetes Mellitus
Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER